{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T23:43:56Z","timestamp":1785541436371,"version":"3.56.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,4,29]],"date-time":"2010-04-29T00:00:00Z","timestamp":1272499200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1007\/s11882-010-0117-z","type":"journal-article","created":{"date-parts":[[2010,4,28]],"date-time":"2010-04-28T07:28:29Z","timestamp":1272439709000},"page":"236-242","source":"Crossref","is-referenced-by-count":41,"title":["Pathogenesis and Treatment of Pruritus"],"prefix":"10.1007","volume":"10","author":[{"given":"Malcolm W.","family":"Greaves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,4,29]]},"reference":[{"key":"117_CR1","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S0140-6736(03)12570-6","volume":"361","author":"G Yosipovitch","year":"2003","unstructured":"Yosipovitch G, Greaves MW, Schmelz M: Itch. Lancet 2003, 361:690\u2013694.","journal-title":"Lancet"},{"key":"117_CR2","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000080898","volume":"135","author":"MW Greaves","year":"2004","unstructured":"Greaves MW, Khalifa N: Itch\u2014more than skin deep. Int Arch Allergy Immunol 2004, 135:166\u2013172.","journal-title":"Int Arch Allergy Immunol"},{"key":"117_CR3","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1172\/JCI28553","volume":"116","author":"R Paus","year":"2006","unstructured":"Paus R, Schmelz M, Biro T, Steinhoff M: Frontiers in pruritus research: scratching the brain for more effective therapy. J Clin Invest 2006, 116:1174\u20131186.","journal-title":"J Clin Invest"},{"key":"117_CR4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/qjmed\/hcg002","volume":"96","author":"R Twycross","year":"2003","unstructured":"Twycross R, Greaves MW, Handwerker H, et al.: Itch: scratching more than the surface. Q J Med 2003, 96:7\u201326.","journal-title":"Q J Med"},{"key":"117_CR5","first-page":"142","volume":"7","author":"M Frey","year":"1922","unstructured":"Frey M: Zur Physiologie der Juckempfinding [in German]. Arch Neurol Physiol Neerl 1922, 7:142\u2013145.","journal-title":"Arch Neurol Physiol Neerl"},{"key":"117_CR6","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1006\/bbrc.2002.6393","volume":"291","author":"K Inoue","year":"2002","unstructured":"Inoue K, Koizumi S, Fuzuwara S, et al.: Functional vanilloid receptors in cultured human epidermal keratinocytes. Biochem Biophys Res Commun 2002, 291:124\u2013129.","journal-title":"Biochem Biophys Res Commun"},{"key":"117_CR7","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000082563","volume":"210","author":"M Bigliardi-Qi","year":"2005","unstructured":"Bigliardi-Qi M, Lipp B, Sumanovski LT, et al.: Changes of epidermal mu-opiate receptor expression and nerve endings in atopic dermatitis. Dermatology 2005, 210:91\u201399.","journal-title":"Dermatology"},{"key":"117_CR8","first-page":"S102","volume":"129","author":"C Pincelli","year":"2009","unstructured":"Pincelli C: Neurotrophins in healthy and diseased skin [abstract]. J Invest Dermatol 2009, 129:S102.","journal-title":"J Invest Dermatol"},{"key":"117_CR9","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jaci.2006.08.034","volume":"119","author":"PJ Dunford","year":"2007","unstructured":"\u2022 Dunford PJ, Williams KN, Desai PJ, et al.: Histamine H4 receptor antagonists are superior to traditional antihistamines in the attenuation of experimental pruritus. J Allergy Clin Immunol 2007, 119:176\u2013183. Discovery of the H4 receptor and its potential role in itching offers the prospect of novel therapeutic approaches to treatment of itch.","journal-title":"J Allergy Clin Immunol"},{"key":"117_CR10","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nature719","volume":"416","author":"DD McKemy","year":"2002","unstructured":"McKemy DD, Neuhasser WM, Julius D: Identification of a cold receptor reveals a general role for TRP channels in thermosensation. Nature 2002, 416:52\u201358.","journal-title":"Nature"},{"key":"117_CR11","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1046\/j.1523-1747.2000.00193.x","volume":"115","author":"U Darsow","year":"2000","unstructured":"Darsow U, Drzezga A, Frisch M, et al.: Processing of histamine-induced itch in the human cerebral cortex: a correlation analysis with dermal reactions. J Invest Dermatol 2000, 115:1029\u20131033.","journal-title":"J Invest Dermatol"},{"key":"117_CR12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/82956","volume":"4","author":"M Schmelz","year":"2001","unstructured":"Schmelz M: A neural pathway for itch. Nat Neurosci 2001, 4:9\u201310.","journal-title":"Nat Neurosci"},{"key":"117_CR13","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/82924","volume":"4","author":"D Andrew","year":"2001","unstructured":"Andrew D, Craig AD: Spinothalamic lamina 1 neurons selectively sensitive to histamine: a central neural pathway for itch. Nat Neurosci 2001, 4:72\u201377.","journal-title":"Nat Neurosci"},{"key":"117_CR14","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0304-3959(03)00249-5","volume":"105","author":"H Mochizuki","year":"2003","unstructured":"Mochizuki H: Imaging of central itch modulation in the human brain using positron emission tomography. Pain 2003, 105:339\u2013346.","journal-title":"Pain"},{"key":"117_CR15","first-page":"209","volume":"21","author":"PD Wall","year":"1985","unstructured":"Wall PD, McMahon SB: Microneuronography and its relation to perceived sensation. A critical review. Pain 1985, 21:209\u2013229.","journal-title":"A critical review. Pain"},{"key":"117_CR16","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/sj.bjp.0705754","volume":"142","author":"JK Bell","year":"2004","unstructured":"Bell JK, McQueen DS, Rees JL: Involvement of histamine H4 and H1 receptors in scratching induced by histamine receptor agonists in Balb C mice. Br J Pharmacol 2004, 142:374\u2013380.","journal-title":"Br J Pharmacol"},{"key":"117_CR17","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0166-2236(03)00208-X","volume":"26","author":"N Vergnolle","year":"2003","unstructured":"Vergnolle N, Ferazzini M, D\u2019Andrea MR, et al.: Proteinase-activated receptors: novel signals for peripheral nerves. Trends Neurosci 2003, 26:496\u2013500.","journal-title":"Trends Neurosci"},{"key":"117_CR18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0304-3959(88)90085-1","volume":"33","author":"JC Ballantyne","year":"1988","unstructured":"Ballantyne JC, Loach AB, Carr DB: Itching after epidural and spinal opiates. Pain 1988, 33:19\u201360.","journal-title":"Pain"},{"key":"117_CR19","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/0016-5085(92)90102-5","volume":"102","author":"NV Bergasa","year":"1992","unstructured":"Bergasa NV, Talbot TL, Alling DW, et al.: A controlled trial of naloxone infusions for the pruritus of chronic cholestasis. Gastroenterology 1992, 102:544\u2013559.","journal-title":"Gastroenterology"},{"key":"117_CR20","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1007\/BF00374079","volume":"287","author":"CF Wahlgren","year":"1995","unstructured":"Wahlgren CF, Tengvall Linder M, Hagermark O, Scheynius A: Itch and inflammation induced by intradermally injected interleukin-2 in atopic dermatitis patients and healthy subjects. Arch Dermatol Res 1995, 287:572\u2013580.","journal-title":"Arch Dermatol Res"},{"key":"117_CR21","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.cytogfr.2008.08.003","volume":"19","author":"Q Zhang","year":"2008","unstructured":"\u2022 Zhang Q, Putheu P, Zhou Q, et al.: Structure and biological functions of IL-31 and IL-31 receptors. Cytokine Growth Factor Rev 2008, 19:347\u2013356. The recent discovery of interleukin-31 and its receptor, which is overexpressed in the itchy skin of atopic dermatitis, promises a new therapeutic approach to antipruritic therapy in this disorders.","journal-title":"Cytokine Growth Factor Rev"},{"key":"117_CR22","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jaci.2005.10.033","volume":"117","author":"E Sonkoly","year":"2006","unstructured":"Sonkoly E, Muller A, Lauerma AI, et al.: IL-31: a new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol 2006, 117:411\u2013417.","journal-title":"J Allergy Clin Immunol"},{"key":"117_CR23","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/ni1084","volume":"5","author":"SR Dillon","year":"2004","unstructured":"Dillon SR, Sprecher C, Hammond A, et al.: Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol 2004, 5:752\u2013760.","journal-title":"Nat Immunol"},{"key":"117_CR24","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/j.1365-2133.2009.09311.x","volume":"161","author":"A Tanaka","year":"2009","unstructured":"Tanaka A, Arita K, Lai-Chong JE, et al.: New insight into mechanisms of pruritus from molecular studies on familial primary localised cutaneous amyloidosis. Br J Dermatol 2009, 161:1217\u20131224.","journal-title":"Br J Dermatol"},{"key":"117_CR25","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1007\/s00403-001-0285-8","volume":"293","author":"O Johansson","year":"2002","unstructured":"Johansson O, Liang Y, Emtestam L: Increased nerve growth factor and tyrosine kinase- like immunoreactivities in prurigo nodularis skin: an exploration of the cause of neurohyperplasia. Arch Derm Res 2002, 293:614\u2013619.","journal-title":"Arch Derm Res"},{"key":"117_CR26","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1292\/jvms.67.915","volume":"67","author":"A Tanaka","year":"2005","unstructured":"Tanaka A, Matsuda H: Expression of nerve growth factor in itchy skins of atopic NC\/NgaTnd mice. J Vet Med Sci 2005, 67:915\u2013919.","journal-title":"J Vet Med Sci"},{"key":"117_CR27","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1111\/j.1365-2133.2007.07935.x","volume":"156","author":"S-E Chang","year":"2007","unstructured":"Chang S-E, Han S-S, Jung H-J, Choi J-H: Neuropeptides and their receptors in psoriatic skin in relation to pruritus. Br J Dermatol 2007, 156:1272\u20131277.","journal-title":"Br J Dermatol"},{"key":"117_CR28","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1365-2133.2002.04803.x","volume":"147","author":"M Toyoda","year":"2002","unstructured":"Toyoda M, Nakamura M, Makino T, et al.: Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis. Br J Dermatol 2002, 147:71\u201379.","journal-title":"Br J Dermatol"},{"key":"117_CR29","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/S0140-6736(96)04176-1","volume":"348","author":"G Peer","year":"1996","unstructured":"Peer G, Kivity S, Agami O, et al.: Randomised cross-over trial of naltrexone in uremic pruritus. Lancet 1996, 348:1552\u20131554.","journal-title":"Lancet"},{"key":"117_CR30","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1681\/ASN.V113514","volume":"11","author":"C Pauli-Magnus","year":"2000","unstructured":"Pauli-Magnus C, Mikus G, Alscher DM, et al.: Naltrexone does not relieve uremic pruritus. Results of a randomised double blind, placebo controlled cross over study. J Am Soc Nephrol 2000, 11:514\u2013519.","journal-title":"J Am Soc Nephrol"},{"key":"117_CR31","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0190-9622(08)80975-9","volume":"24","author":"KL Tan","year":"1991","unstructured":"Tan KL, Haberman HF, Coldman AJ: Identifying effective treatments for uremic pruritus. J Am Acad Dermatol 1991, 24:811\u2013818.","journal-title":"J Am Acad Dermatol"},{"key":"117_CR32","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/0024-3205(93)90569-O","volume":"53","author":"NV Bergasa","year":"1993","unstructured":"Bergasa, NV, Thomas DA, Vergalla J, et al.: Plasma from patients with pruritus of cholestasis induces opioid receptor-mediated scratching in monkeys. Life Sci 1993, 53:1253\u20131257.","journal-title":"Life Sci"},{"key":"117_CR33","first-page":"657","volume":"355","author":"J Goulis","year":"1999","unstructured":"Goulis, J, Leandro G, Burroughs AK: Randomised controlled trials of ursodeoxycholic acid therapy for primary biliary cirrhosis: a meta analysis. Lancet 1999, 355:657\u2013658.","journal-title":"Lancet"},{"key":"117_CR34","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/0016-5085(88)90442-8","volume":"94","author":"CN Ghent","year":"1988","unstructured":"Ghent CN, Carruthers SG: Treatment of pruritus in primary biliary cirrhosis with rifampicin: results of a double blind crossover randomised trial. Gastroenterology 1988, 94:488\u2013493.","journal-title":"Gastroenterology"},{"key":"117_CR35","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S0140-6736(89)91608-5","volume":"638","author":"L Bachs","year":"1989","unstructured":"Bachs L, Pares A, Elena M, et al.: Comparison of rifampicin with phenobarbitone for the treatment of pruritus in biliary cirrhosis. Lancet 1989, 638:574\u2013576.","journal-title":"Lancet"},{"key":"117_CR36","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0190-9622(99)70117-9","volume":"41","author":"N Bergasa","year":"1999","unstructured":"Bergasa N, Alling DW, Talbot TL, et al.: Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: a controlled study. J Am Acad Dermatol 1999, 41:431\u2013444.","journal-title":"J Am Acad Dermatol"},{"key":"117_CR37","doi-asserted-by":"crossref","first-page":"161","DOI":"10.7326\/0003-4819-123-3-199508010-00001","volume":"123","author":"N Bergasa","year":"1995","unstructured":"Bergasa N, Alling DW, Talbot TL, et al.: Naloxone ameliorates the pruritus of cholestasis: results of a double blind, randomized, placebo-controlled trial. Ann Intern Med 1995, 123:161\u2013167.","journal-title":"Ann Intern Med"},{"key":"117_CR38","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2337\/diacare.9.3.273","volume":"9","author":"JB Neilly","year":"1986","unstructured":"Neilly JB, Martin A, Simpson N, MacCuish AC: Pruritus in diabetes mellitus: investigation of prevalence and correlation with diabetes control. Diabetes Care 1986, 9:273\u2013275.","journal-title":"Diabetes Care"},{"key":"117_CR39","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2133.1987.tb05846.x","volume":"116","author":"HK Steinman","year":"1987","unstructured":"Steinman HK, Black AK, Lotti TM, et al.: Polycythaemia vera and water-induced pruritus. Blood histamine levels and cutaneous fibrinolytic activity before and after water challenge. Br J Dermatol 1987, 116:329\u2013333.","journal-title":"Br J Dermatol"},{"key":"117_CR40","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1085-5629(05)80053-7","volume":"14","author":"H Peloux Menag\u00e9 du","year":"1995","unstructured":"du Peloux Menag\u00e9 H, Greaves MW: Aquagenic pruritus. Semin Dermatol 1995, 14:313\u2013316.","journal-title":"Semin Dermatol"},{"key":"117_CR41","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-4632.2004.02553.x","volume":"44","author":"JR Ward","year":"2005","unstructured":"Ward JR, Bernhard JD: Willan\u2019s itch and other causes of pruritus in the elderly. Int J Dermatol 2005, 44:267\u2013273.","journal-title":"Int J Dermatol"},{"key":"117_CR42","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMra033121","volume":"351","author":"FER Simons","year":"2004","unstructured":"Simons FER: Advances in H1 antihistamines. N Engl J Med 2004, 351:2203\u20132217.","journal-title":"N Engl J Med"},{"key":"117_CR43","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1001\/archderm.135.12.1522","volume":"135","author":"PA Klein","year":"1999","unstructured":"Klein PA, Clark RAE: An evidence-based review of the efficacy of antihistamines in relieving the pruritus of atopic dermatitis. Arch Dermatol 1999, 135:484\u2013488.","journal-title":"Arch Dermatol"},{"key":"117_CR44","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1472-8206.1990.tb00482.x","volume":"4","author":"A Figueiredo","year":"1990","unstructured":"Figueiredo A, Ribeiro A, Goncalo M, et al.: Mechanism of action of doxepin in the treatment of chronic urticaria. Fundam Clin Pharmacol 1990, 4:147\u2013158.","journal-title":"Fundam Clin Pharmacol"},{"key":"117_CR45","first-page":"553","volume":"41","author":"D Metze","year":"1999","unstructured":"Metze D, Reimann S, Beissert S, Luger T: Efficacy and safety of naltrexone, an oral opiate receptor antagonist, in the treatment of pruritus in internal and dermatological diseases. J Am Acad Dermatol 1999, 41:553\u2013559.","journal-title":"J Am Acad Dermatol"},{"key":"117_CR46","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jaad.2005.12.010","volume":"54","author":"AG Dawn","year":"2006","unstructured":"Dawn AG, Yosipovitch G: Butorphenol for treatment of intractable pruritus. J Am Acad Dermatol 2006, 54:527\u2013531.","journal-title":"J Am Acad Dermatol"},{"key":"117_CR47","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1056\/NEJMc0906670","volume":"361","author":"A Duval","year":"2009","unstructured":"\u2022 Duval A, Dubetret L: Aprepitant as an antipruritic agent? N Engl J Med 2009, 361:1415\u20131416. This neurokinin receptor antagonist has been shown to ameliorate one of the most intractable generalized itches\u2014the pruritus of S\u00e9zary syndrome.","journal-title":"N Engl J Med"},{"key":"117_CR48","first-page":"462","volume":"26","author":"IJP Esch De","year":"2005","unstructured":"De Esch IJP, Thurmond RL, Jongelan A, Leurs R: The histamine H4 receptor as a new therapeutic target for inflammation. Trends Pharmacol Sci 2005, 26:462\u2013469.","journal-title":"Trends Pharmacol Sci"},{"key":"117_CR49","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2340\/0001555575434436","volume":"75","author":"M Vogelsang","year":"1995","unstructured":"Vogelsang M, Heyer G, Hornstein OP: Acetyl choline induces different sensations in atopic and non-atopic subjects. Acta Derm Venereol 1995, 75:434\u2013436.","journal-title":"Acta Derm Venereol"},{"key":"117_CR50","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1038\/jid.2009.155","volume":"129","author":"T Andoh","year":"2009","unstructured":"Andoh T, Saito A, Kuraishi Y: Leukotriene B4 mediates sphingosylphosphorylcholine-induced itch-associated responses in mouse skin. J Invest Dermatol 2009, 129:2854\u20132860.","journal-title":"J Invest Dermatol"},{"key":"117_CR51","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1529-8019.2005.00032.x","volume":"18","author":"J Rivard","year":"2005","unstructured":"Rivard J, Lim HW: Ultraviolet phototherapy for pruritus. Dermatol Ther 2005, 18:344\u2013354.","journal-title":"Dermatol Ther"},{"key":"117_CR52","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jaad.2004.08.050","volume":"52","author":"MI Duque","year":"2005","unstructured":"Duque MI, Yosipovitch G, Fleischer AB, et al.: Lack of efficacy of tacrolimus ointment 0.1% for the treatment of hemodialysis-related pruritus: a randomized, double-blind, vehicle-controlled study. J Am Acad Dermatol 2005, 52:519\u2013521.","journal-title":"J Am Acad Dermatol"},{"key":"117_CR53","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0272-6386(00)70251-4","volume":"35","author":"SD Ashmore","year":"2000","unstructured":"Ashmore SD, Jones CH, Newstead CD, et al.: Odansetron therapy for uremic pruritus in hemodialysis patients. Am J Kidney Dis 2000, 35:827\u2013831.","journal-title":"Am J Kidney Dis"},{"key":"117_CR54","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1093\/ndt\/gfh496","volume":"19","author":"AI Gunal","year":"2004","unstructured":"Gunal AI, Ozalp G, Yoldas TK, et al.: Gabapentin therapy for pruritus in haemodialysis patients: a randomized, placebo-controlled, double-blind trial. Nephrol Dial Transplant 2004, 19:3137\u20133139.","journal-title":"Nephrol Dial Transplant"},{"key":"117_CR55","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1681\/ASN.2005020152","volume":"16","author":"B Wikstrom","year":"2005","unstructured":"Wikstrom B, Gellert R, Ladefoged SD, et al.: Kappa-opioid system in uremic pruritus: multicenter, randomized, double\u2013blind, placebo-controlled clinical studies. J Am Soc Nephrol 2005, 16:3742\u20133747.","journal-title":"J Am Soc Nephrol"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-010-0117-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11882-010-0117-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-010-0117-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T04:06:30Z","timestamp":1711425990000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11882-010-0117-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,29]]},"references-count":55,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["117"],"URL":"https:\/\/doi.org\/10.1007\/s11882-010-0117-z","relation":{},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"value":"1529-7322","type":"print"},{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,29]]}}}